Xyzal
Xyzal Price range: $ 47,00 through $ 252,00
Back to products
Zanaflex
Zanaflex Price range: $ 40,00 through $ 285,00

Yasmin

Price range: $ 63,00 through $ 223,00

Yasmin is a combination oral contraceptive used primarily to provide reliable protection against unplanned pregnancy. It contains two active hormones, drospirenone and ethinyl estradiol, which work together to inhibit ovulation and alter the cervical mucus. This medication is also officially approved to treat the emotional and physical symptoms of premenstrual dysphoric disorder (PMDD). Additionally, Yasmin helps manage moderate acne in women who have reached menarche and desire an oral contraceptive for birth control. When taken consistently every day, it helps regulate the menstrual cycle and can reduce the severity of monthly cramps.

Active substance: drospirenone, ethinylestradiol
SKU: Yasmin Categories: ,
Delivery: 5–21 days (depending on the shipping method)
Extra 10% discount with coupon: IT4K6SVM

Each dosage option has its own packaging choices.

Description

Yasmin belongs to a group of medicines known as combination hormonal oral contraceptives. It contains two active synthetic hormones, drospirenone and ethinyl estradiol, which work together to prevent pregnancy. In accordance with U.S. Food and Drug Administration (FDA) regulations, Yasmin is a prescription-only medication that requires clinical evaluation by a licensed healthcare provider prior to initiation.

This reference text provides an objective overview of Yasmin’s clinical profile, pharmacokinetics, potential side effects, and practical guidance for daily use. Patients should review this information alongside the official patient package insert provided with their prescription.

Active Ingredients Drospirenone (3 mg) / Ethinyl Estradiol (0.03 mg)
Therapeutic Class Combined Synthetic Estrogen and Progestin Oral Contraceptive
Dosage Form Oral Tablet
Route of Administration Oral
Primary Purpose Pregnancy Prevention
Storage Controlled room temperature (68°F to 77°F / 20°C to 25°C)

Clinical Overview and Usage

Main Uses

Yasmin is indicated primarily as a combination oral contraceptive for females of reproductive potential who elect to use this method to prevent pregnancy. The dual-hormone formulation relies on strict daily compliance to maintain suppressive hormonal concentrations. On one hand, combination oral contraceptives offer high statistical efficacy when taken correctly; on the other hand, non-adherence significantly increases the risk of unintended pregnancy. While some healthcare providers may evaluate off-label applications–such as regulating cycle predictability or managing dysmenorrhea–these uses are distinct from official FDA indications. Patients seeking management for acne vulgaris or premenstrual dysphoric disorder (PMDD) should note that Yasmin is not specifically indicated for these conditions, unlike certain other drospirenone-containing formulations.

How the Drug Works

The primary mechanism by which Yasmin prevents pregnancy is the suppression of gonadotropins, which leads to the inhibition of ovulation. Ethinyl estradiol provides synthetic estrogenic activity, suppressing follicle-stimulating hormone (FSH), while drospirenone acts as a synthetic progestin to inhibit luteinizing hormone (LH). In addition to preventing follicular maturation and release, the medication causes changes in the cervical mucus, creating a physical barrier that hinders sperm penetration into the uterine cavity. Furthermore, alterations in the endometrium decrease the likelihood of blastocyst implantation. Drospirenone is an analog of spironolactone and exhibits antimineralocorticoid activity, which influences fluid dynamics and serum electrolyte balance.

Dosing Schedule

Yasmin is supplied in blister packs formatted for a 28-day continuous dosing cycle. Each pack contains 21 active yellow tablets (each containing 3 mg drospirenone and 0.03 mg ethinyl estradiol) followed by 7 inactive white tablets. Patients must take one tablet by mouth at the same time every day to maintain constant serum hormone levels. Dosing regimens can begin using either a Day 1 Start (taking the first yellow tablet on the first day of menses) or a Sunday Start (taking the first tablet on the first Sunday following the onset of menses, utilizing a non-hormonal back-up contraceptive for the first 7 days). Complete adherence to the sequence of 21 active days followed by 7 inactive days is necessary to maintain contraceptive efficacy.

What Happens in the Body

Following oral administration, both drospirenone and ethinyl estradiol are rapidly absorbed through the gastrointestinal tract. Drospirenone reaches peak serum concentrations within 1 to 2 hours, exhibiting an absolute bioavailability of approximately 76%. Ethinyl estradiol also reaches peak concentrations in 1 to 2 hours, but has an absolute bioavailability of about 40% due to first-pass hepatic metabolism. Drospirenone binds extensively to serum albumin without binding to sex hormone-binding globulin (SHBG), whereas ethinyl estradiol binds heavily to albumin and induces elevated SHBG concentrations. Drospirenone is cleared via metabolic pathways involving CYP3A4, displaying a terminal elimination half-life of roughly 30 hours. Ethinyl estradiol has an elimination half-life of approximately 24 hours, with metabolites excreted in both urine and feces.

Safety Profile and Patient Guidance

Compatibility with Other Medicines

Co-administration of Yasmin with cytochrome P450 enzyme inducers can lower plasma hormone concentrations, potentially reducing contraceptive efficacy or increasing breakthrough bleeding. Drugs such as rifampin, carbamazepine, phenytoin, phenobarbital, topiramate, and herbal supplements containing St. John’s wort significantly accelerate hepatic clearance. Conversely, strong CYP3A4 inhibitors like ketoconazole, itraconazole, or diltiazem may elevate drospirenone exposure. Because drospirenone possesses antimineralocorticoid activity, concurrent use with agents that promote potassium retention–including angiotensin-converting enzyme (ACE) inhibitors, angiotensin receptor blockers (ARBs), potassium-sparing diuretics, or chronic nonsteroidal anti-inflammatory drugs (NSAIDs)–warrants monitoring of serum potassium during the first treatment cycle in high-risk individuals.

Adverse Reactions

Commonly reported adverse reactions associated with Yasmin include nausea, breast tenderness, irregular uterine bleeding or spotting, headache, and minor changes in body weight or mood. These side effects frequently decrease in intensity after the initial 2 to 3 cycles of use. On one hand, minor side effects are generally manageable; on the other hand, combined oral contraceptives carry serious cardiovascular risks. Combination hormonal contraceptives increase the risk of arterial and venous thromboembolic events. Observational studies indicate that contraceptives containing drospirenone may carry a higher risk of venous thromboembolism (VTE), such as deep vein thrombosis and pulmonary embolism, compared to those containing progestins like levonorgestrel.

If You Skip a Dose

If one active tablet is missed, take it as soon as remembered, then take the next tablet at the regular time, even if two tablets are taken on the same day. If two active tablets are missed sequentially during Week 1 or Week 2, take two tablets on the day remembered and two tablets the next day, continuing with one tablet daily thereafter; non-hormonal back-up contraception (such as condoms) must be used for 7 consecutive days. If two active tablets are missed during Week 3, or if three or more active tablets are missed at any time during the cycle, follow the specific instructions on the prescription label regarding restarting the pack and maintain back-up contraception for at least 7 days.

What to Avoid While Taking It

Yasmin may be taken with or without food. Taking the dose with meals or at bedtime often mitigates early gastrointestinal side effects such as nausea. Moderate alcohol consumption does not directly alter the metabolic clearance of drospirenone or ethinyl estradiol; however, alcohol impairment increases the probability of forgotten doses. Patients should exercise caution regarding high-dose potassium supplements or salt substitutes containing potassium chloride if they possess risk factors for hyperkalemia or take concurrent potassium-sparing agents.

Red Flags

Emergency medical evaluation is required if signs of major vascular or systemic complications arise. Patients must seek immediate care if they experience severe chest pain, sudden dyspnea, pain or swelling in one calf, severe localized headache, sudden visual disturbances, slurred speech, or acute severe abdominal pain. These manifestations may indicate deep vein thrombosis, pulmonary embolism, myocardial infarction, or stroke. Immediate medical consultation is also warranted if jaundice develops or if severe hypersensitivity reactions occur.

Important Precautions

Yasmin is contraindicated in females with a history of or active venous thromboembolism, arterial thromboembolic disease, hepatic adenomas or carcinomas, renal impairment, adrenal insufficiency, or known or suspected estrogen-dependent neoplasia such as breast cancer. Cigarette smoking increases the risk of serious cardiovascular events from combination oral contraceptive use. This risk increases with age (particularly in women over 35 years) and with heavy smoking (15 or more cigarettes per day); therefore, Yasmin is contraindicated in this demographic. The medication is not indicated during pregnancy. Small amounts of contraceptive steroids pass into breast milk, and estrogenic components may decrease milk yield; alternative non-hormonal methods are recommended until weaning is complete.

Storage and Expiration

Store Yasmin tablets at controlled room temperature between 68°F and 77°F (20°C to 25°C), with excursions permitted between 59°F and 86°F (15°C to 30°C). Keep the blister pack inside its outer carton to protect the contents from excessive light and humidity. Store safely out of reach of children and pets. Do not use tablets beyond the expiration date stamped on the packaging, and consult a pharmacist or local authority regarding proper drug disposal protocols.

Common Questions

What should I do if I experience nausea when starting Yasmin?

Nausea is a common mild side effect during the first few weeks of starting hormonal contraception. Taking your daily tablet with a meal or immediately before sleep can help minimize gastrointestinal discomfort. If nausea persists beyond three months or becomes severe, consult your healthcare provider to evaluate your regimen.

How does drospirenone differ from progestins used in older birth control pills?

Drospirenone is a synthetic progestin derived from spironolactone, giving it unique antimineralocorticoid properties. Unlike older progestins, it can help prevent fluid retention in some individuals. However, its specific metabolic profile requires attention to potassium levels in patients with renal or cardiovascular vulnerabilities.

Can taking Yasmin cause elevations in serum potassium levels?

Because drospirenone acts as a mild potassium-sparing agent, elevated potassium is possible, particularly in individuals with pre-existing renal dysfunction or those taking potassium-elevating drugs like ACE inhibitors. Healthy women taking Yasmin typically do not experience clinically significant potassium changes, but screening may be advised for high-risk patients.

Will taking common antibiotics decrease the effectiveness of Yasmin?

Most broad-spectrum antibiotics (such as amoxicillin or doxycycline) do not significantly lower combination oral contraceptive concentrations. However, enzyme-inducing antibiotics like rifampin significantly reduce effectiveness, requiring secondary non-hormonal protection. Always inform your provider of any concurrent antibiotic prescriptions.

How quickly does fertility return after discontinuing Yasmin?

Ovulation usually resumes within a few weeks to months after stopping Yasmin. Most females regain their baseline fertility patterns rapidly, though temporary delays in menstrual regularity can occur as the natural hypothalamic-pituitary-ovarian axis readjusts.

In accordance with FDA requirements.

This text is for informational purposes only and does not constitute individual medical advice.

Additional information
Dosage

0.03mg+3mg

Package

42 pills

,

63 pills

,

84 pills

,

126 pills

,

168 pills

Ενεργός Ουσία

,